TSS
TELO icon

Two Sigma Securities’s Telomir Pharmaceuticals TELO Stock Holding History

Two Sigma Securities’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,004
Closed -$13.3K – 2292
2025
Q4 		$13.3K Buy
+10,004
New +$14.4K ﹤0.01% 1252
2025
Q3 		– Sell
-22,911
Closed -$28.6K – 2092
2025
Q2 		$28.6K Buy
+22,911
New +$53K ﹤0.01% 1160

Other funds holding TELO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return

Two Sigma Securities's TELO Position: Q1 2026 in Review

Two Sigma Securities sold out of Telomir Pharmaceuticals (TELO) in Q1 2026, closing a stake of 10,004 shares — an estimated $13.3K sold.

Two Sigma Securities first reported a position in TELO in Q2 2025 and held it in 2 quarters. The position peaked at $28.6K in Q2 2025. 27 funds tracked by Wall St. Rank hold TELO as of Q1 2026.

  • Two Sigma Securities reported no remaining Telomir Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 10,004 Telomir Pharmaceuticals shares in Q1 2026, an estimated $13.3K.
  • Two Sigma Securities first reported a position in Telomir Pharmaceuticals in Q2 2025 and held it in 2 quarters.
  • Two Sigma Securities's Telomir Pharmaceuticals position peaked at $28.6K in Q2 2025.
  • 27 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.